Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity

Clinical and Experimental Immunology

Volumn 116, Issue 2, 1999, Pages 299-306

  Bartholdy, C ^a   Nansen, A ^a   Marker, O ^a   Thomsen, Allan Randrup ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Innate immunity; Soluble TNF receptor I and II in serum; T cell mediated immunity IFN ; Viral infection

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNITY; INTERFERON PRODUCTION; MACROPHAGE ACTIVATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS SHEDDING;

EID: 0032948299     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00903.x     Document Type: Article

References (47)

1. 1 Rothe J, Lesslauer W, Lotscher H et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364:798-802.
2. 2 Pfeffer K, Matsuyama T, Kundig TM et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73:457-67.
3. 3 Peschon JJ, Torrance DS, Stocking KL et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998; 160:943-52.
4. 4 Erickson SL, de Sauvage FJ, Kikly K et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994; 372:560-3.
5. 5 Tsujimoto M, Yip YK, Vilcek J. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol 1986; 136:2441-4.
6. 6 Ruggiero V, Tavernier J, Fiers W et al. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol 1986; 136:2445-50.
7. 7 Aderka D, Englemann H, Hornik V et al. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51:5602-7.
8. 8 Aukrust P, Liabakk NB, Muller F et al. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J Inf Dis 1994; 169:420-4.
9. 9 Zangerle R, Gallati H, Sarcletti M et al. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Immunol Letters 1994; 41:229-34.
10. 10 Kalinkovich A, Engelmann H, Harpaz N et al. Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 1992; 89:351-5.
11. 11 van der Poll T, Jansen J, van Leenen D et al. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Inf Dis 1993; 168:955-60.
12. 12 Diez-Ruiz A, Tilz GP, Zangerle R et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54:1-8.
13. 13 Miyawaki T, Kasahara Y, Kanegane H et al. Expression of CD45RO (UCHLI) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis. Clin Exp Immunol 1991; 83:447-51.
14. 14 Ward BJ, Johnson RT, Vaisberg A et al. Spontaneous proliferation of peripheral mononudear cells in natural measles virus infection: identification of dividing cells and correlation with mitogen responsiveness. Clin Immunol Immunopathol 1990; 55:315-26.
15. 15 Griffin DE, Ward BJ, Jauregui E et al. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Inf Dis 1990; 161:449-53.
16. 16 Carding SR, Allan W, McMickle A et al. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J Exp Med 1993; 177:475-82.
17. 17 Andersson EC, Christensen JP, Marker O et al. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol 1994; 152:1237-45.
18. 18 Colle JH, Saron MF, Shidani B et al. High frequency of T lymphocytes committed to interferon-gamma transcription upon polyclonal activation in spleen from lymphocytic choriomeningitis virus-infected mice. Int Immunol 1993; 5:435-41.
19. 19 Nansen A, Christensen JP, Marker O et al. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: role of T cell-dependent production of interferon-gamma. J Inf Dis 1997; 176:151-7.
20. 20 Christensen JP, Ropke C, Thomsen AR. Virus-induced polyclonal T cell activation is followed by apoptosis: partitioning of CD8+ T cells based on alpha 4 integrin expression. Int Immunol 1996; 8:707-15.
21. 21 Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178:427-38.
22. 22 Kasaian MT, Biron CA. The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo. J Immunol 1989; 142:1287-92.
23. 23 Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8:177-87.
24. 24 Buchmeier MJ, Welsh RM, Dutko FJ et al. The virology and immunobiology of lymphocytic choriomeningitis virus infection. [Review] [180 refs]. Adv Immunol 1980; 30:275-331.
25. 25 Thomsen AR, Pfau CJ. Influence of host genes on the outcome of murine lymphocytic choriomeningitis virus infection. In: Salvato MS, ed. The arenaviridae. New York: Plenum Press, 1993:199-224.
26. 26 Muller U, Steinhoff U, Reis LF et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264:1918-21.
27. 27 Zinkernagel RM, Althage A, Holland J. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. J Immunol 1978; 121:744-8.
28. 28 Schattner A, Meshorer A, Wallach D. Involvement of interferon in virus-induced lymphopenia. Cell Immunol 1983; 79:11-25.
29. 29 Marker O, Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J Exp Med 1973; 137:1511-25.
30. 30 Thomsen AR, Nansen A, Andersen C et al. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int Immunol 1997; 9:1757-66.
31. 31 Nansen A, Christensen JP, Ropke C et al. Role of interferon-γ in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-γ knock-out mice. J Neuroimmunol 1998; 86:202-12.
32. 32 Christensen JP, Andersson EC, Scheynius A et al. Alpha 4 integrin directs virus-activated CD8+ T cells to sites of infection. J Immunol 1995; 154:5293-301.
33. 33 Andersson EC, Christensen JP, Scheynius A et al. Lymphocytic choriomeningitis virus infection is associated with long-standing perturbation of LFA-1 expression on CD8+ T cells. Scand J Immunol 1995; 42:110-8.
34. 34 Butz EA, Hostager BS, Southern PJ. Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis, Microbial Pathogenesis 1994; 16:283-95.
35. 35 Leist TP, Heuchel R, Zinkernagel RM, Increased bactericidal macrophage activity induced by immunological stimuli is dependent on interferon (IFN)-gamma. Interference of anti-IFN-gamma but not anti-IFN-alpha/beta with modulation of macrophage activity caused by lymphocytic choriomeningitis virus infection or systemic graft-vs.-host reactions. Eur J Immunol 1988; 18:1295-8.
36. 36 Leist TP, Heuchel R, Zinkemagel RM. Increased bactericidal macrophage activity induced by immunological stimuli is dependent on interferon (IFN)-gamma. Interference of anti-IFN-gamma but not anti-IFN-alpha/beta with modulation of macrophage activity caused by lymphocytic choriomeningitis virus infection or systemic graft-vs.-host reactions. Eur J Immunol 1988; 18:1295-8.
37. 37 Stout RD. Macrophage activation by T cells: cognate and non-cognate signals. Curr Opin Immunol 1993; 5:398-403.
38. 38 Stout RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996; 17:487-92.
39. 39 Dalton DK, Pitts-Meek S, Keshav S et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259:1739-42.
40. 40 Cope AP, Aderka D, Wallach D et al. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology 1995; 84:21-30.
41. 41 Girardin E, Roux-Lombard P, Grau GE et al. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology 1992; 76:20-23.
42. 42 van Deuren M, van der Ven-Jongekrijg J, Demacker PN et al. Differential expression of proinflammatory cytokinnes and their inhibitors during the course of meningococcal infections. J Infect Dis 1994; 169:157-61.
43. 43 Carpenter A, Evans TJ, Buurman WA et al. Differences in the shedding of soluble TNF receptors between endotoxin-sensitive and endotoxin-resistant mice in response to lipopolysaccharide or live bacterial challenge. J Immunol 1995; 155:2005-12.
44. 44 Zangerle R, Fuchs D, Sarcletti M et al. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection. Clin Immunol Immunopathol 1994; 72:328-34.
45. 45 Soong L, Xu JC, Grewal IS et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amaconensis infection. Immunity 1996; 4:263-73.
46. 46 Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 1997; 185:2089-94.
47. 47 Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272:1947-50.